Sotyktu 6 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FEUW9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,701
Award facts
- Contract value 100% obligated
- $24,700.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24.7K delivery order to AmerisourceBergen Drug Corp for Sotyktu 6 mg tablets (30-count) on June 24, 2025, with an ultimate completion date of July 16, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9M global pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company's IDC with DLA provides comprehensive pharmaceutical and medical supply support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The DLA has signaled its intent to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards involving at least three different contractors, positioning AmerisourceBergen as a key vendor within this evolving procurement framework. Sotyktu is a prescription immunosuppressant used in the treatment of atopic dermatitis, reflecting the breadth of specialized pharmaceutical commodities the company supplies through its federal contract portfolio.
Quick answers
Who was awarded contract SPE2DB25FEUW9?
SPE2DB25FEUW9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 24, 2025.
How much is contract SPE2DB25FEUW9 worth?
The government has obligated $24,701 on SPE2DB25FEUW9.
Is contract SPE2DB25FEUW9 an order under another contract?
Yes. SPE2DB25FEUW9 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FEUW9 competed?
The extent of competition for SPE2DB25FEUW9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award